Ireland-based Creganna Medical makes products such as cardiac
stents, balloon catheters and laparoscopic devices used in
cardiovascular, neurovascular and other life-saving treatments
and procedures.
Minimally invasive procedures involve using devices such as
catheters to make tiny incisions instead of creating large
openings on the body.
TE bought another catheter systems maker, AdvancedCath, for $190
million in February 2015.
TE said the deal is expected to add 3 cents per share to
earnings in the first full year after the deal closes, probably
in the third quarter of 2016.
Creganna Medical will be part of TE's industrial solutions
business, which mainly includes communication equipment used in
aerospace, defense, oil, and gas markets.
Morgan Stanley & Co LLC was TE's financial adviser while Davis
Polk & Wardwell LLP was the outside counsel.
(Reporting by Kshitiz Goliya in Bengaluru; Editing by Sriraj
Kalluvila)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
|